2. Benign breast disease

International Journal of Clinical Practice

Volumn 55, Issue 7, 2001, Pages 461-464

  Hamed, H ^a   Fentiman, I S ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BROMOCRIPTINE; DANAZOL; HEMOGLOBIN; TAMOXIFEN;

ADOLESCENT; ADULT; ARTICLE; ASPIRATION; BREAST ABSCESS; BREAST CYST; BREAST DEVELOPMENT; BREAST DISCHARGE; BREAST DISEASE; BREAST DUCT ECTASIA; BREAST FIBROADENOMA; BREAST PAPILLOMA; BREAST SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; INCISION; INVOLUTION; MASTALGIA; MEDICAL ASSESSMENT; MICRODOCHECTOMY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPRODUCTION; THORAX PAIN; WORKLOAD; BREAST TUMOR; CYST; CYSTOSARCOMA PHYLLOIDES; FIBROADENOMA; GYNECOMASTIA; INFECTION; MALE; MASTECTOMY; MASTITIS; METHODOLOGY; NIPPLE; PAIN; REVIEW; SECRETION;

BREAST DISEASES; BREAST NEOPLASMS; CYSTS; FEMALE; FIBROADENOMA; GYNECOMASTIA; HUMANS; INFECTION; MALE; MASTECTOMY; MASTITIS; NIPPLES; PAIN; PHYLLODES TUMOR;

EID: 0034741180     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Hughes LE, Mansel RE, Webster DJT. Aberrations of normal development and involution (ANDI): a new perspective on pathogenesis and nomenclature of benign breast disorders. Lancet 1987; ii: 1316.
2. Wang D Y, Fentiman IS. Epidemiology and endocrinology of benign breast disease. Breast Cancer Res Treat 1985; 6: 5-36.
3. Fentiman IS. Management of breast pain. In: JR Harris, M Lippman, M Morrow, Osborne K, Eds. Diseases of the breast, 2nd edn. Philadelphia; Lippincott Williams & Wilkins, 1999.
4. Mansel RE, Wisbey JR, Hughes LE. Controlled trial of the antigonadotrophin danazol in painful nodular benign breast disease. Lancet 1982; i: 928.
5. Doberl A, Tobiassen T, Rasmussen T. Treatment of recurrent cyclical mastodynia in patients with fibrocystic breast disease. Acta Obstet Gynecol Scand 1984; 123(suppl): 177.
6. Mansel RE, Preece PE, Hughes LE. A double-blind trial of the prolactin inhibitor bromocriptine in painful benign breast disease. Br J Surg 1978; 65:724.
7. Blichert-Toft M, Nyobe Andersen AN, Hendriksen OB, Mygind T. Treatment of mastalgia with bromocriptine: a double-blind cross-over study. BMJ 1979;1: 237.
8. Durning P, Sellwood RA. Bromocriptine in severe cyclical breast pain. Br J Surg 1982; 69: 248.
9. Mansel RE, Dogliotti L. European multicentre trial of bromocriptine in cyclical mastalgia. Lancet 1990; 335: 190.
10. Preece PE, Hanslip JI, Gilbert L et al. Evening primrose oil (Efamol) for mastalgia. In: Horrobin DF, Ed. Clinical uses of essential fatty acids. New York: Eden Press, 1982.
11. Fentiman IS, Caleffi M, Brame K et al. Double-blind controlled trial of tamoxifen therapy for mastalgia. Lancet 1986; i: 287.
12. Messinis IE, Lolis D. Treatment of premenstrual mastalgia with tamoxifen. Acta Obstet Gynecol Scand 1988; 67: 307.
13. Fentiman IS, Caleffi M, Hamed H, Chaudary MA. Dosage and duration of tamoxifen treatment for mastalgia: a controlled trial. Br J Surg 1988; 75: 845.
14. GEMB Group (Grupo de Estudio de Mastopatias Benignas), Argentine. Tamoxifen therapy for cyclical mastalgia: dose randomized trial. Breast 1997; 5:212.
15. Powles TJ, Ford HT, Gazet J-C. A randomised trial to compare tamoxifen with danazol for treatment of benign mammary dysp\asia. Breast Dis 1987;2: 1.
16. Kontostolis E, Stefanidis K, Navrozoglou I, Lolis D. Comparison of tamoxifen with danazol for treatment of cyclical mastalgia. Gynecol Endocrinol 1997; 11: 393.
17. Sandrucci S, Mussa A, Festa V et al. Comparison of tamoxifen and bromocriptine in management of fibrocystic breast disease: a randomized blind study. Ann NYAcadSci 1990; 586: 626.
18. Gregory WM, Mills SP, Hamed HH, Fentiman IS. Applied kinesiology for the treatment of women with mastalgia. Breast 2001; 10: 15-19.
19. Miller WR, Scott WN, Phil M et al. Using biological measurements, can patients with benign breast disease who are at high risk of breast cancer be identified? Cancer Detect Prev 1992; 16: 13-20.
20. Bodian ÇA, Perzin KH, Lattes R et al. Prognostic significance of benign proliferative breast disease. Cancer 1993; 71: 3896-3907.
21. Ciatto S, Biggeri A, Del Turco MR et al. Risk of breast cancer subsequent to proven gross cystic disease. Eur J Cancer 1990; 26: 555-557.
22. Bundred NJ, West RR, Dowd JO et al. Is there an increased risk of breast cancer in women who have had a breast cyst aspirated? Br J Cancer 1991 ; 64: 953-935.
23. Hamed H,Cody A, Chaudary MA, Fentiman IS. Follow-up of patients with aspirated breast cysts: is it necessary? Arch Surg 1989; 21: 253-259.
24. Hinton CP, Dowle C, Locker A et al. Modification of the natural history of cystic disease of the breast by a short course of danazol: evidence from a controlled trial. BrJClin Pract 1982; 42(suppl 56): 56-57.
25. Chaudary MA, Millis RR, Davies GC et al. Nipple discharge: the diagnostic value of testing for occult blood. Ann Surg 1989; 124: 253-255.
26. Nydick M, Bustos J, Dale JH et al. Gynaecomastia in adolescent boys. JAMA 1961; 178: 449-454.
27. Fentiman IS. Detection and treatment of breast cancer. 2nd edn, chapter 19. London: Martin Dunitz, 1998.
28. Hughes LE, Mansel RE, Webster DJT. Benign disorders and diseases of the breast. London: BaillièreTindall, 1989.